After over five years of research and development, Heska Corporation is set to launch Flu Avert I.N. vaccine, the first modified-live virus, intranasal equine influenza vaccine. The proprietary vaccine and intranasal applicator will provide veterinarians with a unique and effective tool to aid in the prevention of equine influenza. The product will be available for veterinary use following

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In